Back to Bank of America Corp. Bank of America Corp.

NPCENPCE

Showing 8 of 15 quarters

Position history for Bank of America Corp.Bank of America Corp.'s holdings in Neuropace, Inc.

Yes. Bank of America holds 20,249 shares of NPCE (Neuropace), worth $321,757, as of its Q2 2026 13F filing. It reduced the position by 4,449 shares (-18.0%) from Q1 2026. Bank of America has held NPCE in every 13F on record since Q4 2022, 15 quarterly filings.

Current Value

$321,757

Current Shares

20,249

Total Value Change

+$228,638

Total Shares Change

+6,889

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
20,249
-18.0%
$321,7570.0%$15.89
0
2026-Q1
Decreased
24,698
-85.5%
$324,7790.0%$13.15
0
2025-Q4
Increased
170,439
+195.5%
$2.6M0.0%$15.44
42
2025-Q3
Increased
57,677
+23.9%
$594,6500.0%$10.31
20
2025-Q2
Decreased
46,553
-64.5%
$518,6000.0%$11.14
0
2025-Q1
Increased
131,175
+436.6%
$1.6M0.0%$12.29
41
2024-Q4
Increased
24,448
+83.0%
$273,5720.0%$11.19
24
2024-Q3
Decreased
13,360
-22.9%
$93,1190.0%$6.68
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used